Our results are further corroborated by two large scale microarray transcriptome studies reporting an approximately 2-fold increase of FAM57A transcript levels in hypoxic breast cancer and hepatic stellate cells [41,42]. This evidence concerns the gene TLCD3A and breast carcinoma.